It is our pleasure to inform you that BioAsia 2019, the 16th edition of the premier annual international life-sciences and healthcare convention is scheduled to be organized at Hyderabad, India during February 25-27, 2019. The event is an initiative of Government of Telangana in partnership with Government of India and NASSCOM. The 15th edition of the convention organized earlier this year attracted 1,800 global healthcare and life sciences leaders from 52 countries. The BioAsia 2019 convention will host an array of activities including business partnering, exhibition, technology conferences with talks from some global thought leaders, interactive sessions, CEO Conclave, startup showcase, visit to life sciences corridors, networking dinners, among others.
BioAsia is a global recognised conference which witnesses participation of most influential Life Sciences and Healthcare leaders from over 50 countries every year. The theme for BioAsia 2019 is “Life Sciences 4.0” focussed on healthcare being re-imagined as a result of technological disruption and rising customer expectations. NASSCOM has partnered with the “Start-up Stage @ BioAsia” which will provide a unique networking and showcase platform to start-ups working on solutions for the pharma, bio-tech, life sciences, health-tech and med-tech sectors.
You will be pleased to note that Startup Stage will enable interaction opportunities with a prestigious visitor line up including a range of industry visionaries and investors including the likes of Mr. Kris Gopalakrishnan (Axilor and Co-Founder, Infosys), Dr. Renu Swarup (Secretary, DBT, Government of India), Mr. Sanjay Kaul (Chrys Capital), Kalaari, Kae, IvyCap, 3One4, Shunwei, RoundGlass, Abraaj, TPG among many others and also M&A / innovation leaders from Zydus Cadila, Dr Reddy’s, Novartis, Piramal, Sun Pharma, Johnson & Johnson, Microsoft, Tech Mahindra, among others. Industry leaders of the likes of Dr. Don W Cleveland (2018 Breakthrough Prize winner and Ludwig Cancer Research, Univ. of California), Dr. Soumya Swaminathan (Dy. Director General, World Health Organization), Ms. Karenann Terrell (Chief Digital and Technology Officer at GSK), Mr. Peter Lee (Corporate Vice President, Microsoft), Dr. Badhri Srinivasan (Global Head of Development, Novartis), Mr. Dilip Sanghvi (MD, Sun Pharma), Mr. Pankaj Patel (CMD, Zydus Cadila), Mr. Satish Reddy (Chairman, Dr. Reddy’s Laboratories), Dr. Urmish Chudgar (Managing Director, Intas Pharma), Dr. Steven Quay (CEO, Atossa Genetics), Ms. Lara Barezza (Managing Director – India, Roche), Dr. Mark Bach (Janssen – Singapore), among many others.
Shortlisted start-ups will also get to:
You are encouraged to apply at Start-up Stage website http://2019.bioasia.in/Startups_announcement.html and block your free exhibition space at the earliest.
For delegates :